.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
McKesson
Cerilliant
Fuji
Dow
Baxter
McKinsey
UBS
Medtronic
Deloitte

Generated: January 16, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin glargine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eli Lilly And CoBASAGLARinsulin glargineSOLUTION;SUBCUTANEOUS205692NDAEli Lilly and Company0002-7715-631 SYRINGE in 1 CARTON (0002-7715-63) > 3 mL in 1 SYRINGE
Eli Lilly And CoBASAGLARinsulin glargineSOLUTION;SUBCUTANEOUS205692NDAEli Lilly and Company0002-7715-595 SYRINGE in 1 CARTON (0002-7715-59) > 3 mL in 1 SYRINGE (0002-7715-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Federal Trade Commission
Accenture
Healthtrust
Harvard Business School
Queensland Health
McKesson
US Department of Justice
Novartis
Dow

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot